The interplay of EGFR, L1CAM, MAPK, and DAP12 signaling pathways plays a crucial role in the progression of TN BC, which is characterized by its lack of hormone receptors and HER2 expression, making it particularly aggressive and difficult to treat. The gene discussed is EGFR; the disease is breast cancer.